Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers

NCT02288000 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02288000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02288000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers
Lead sponsor
University Hospital, Lille
Phase
Phase 1
Overall status
Terminated
Start date
September 14, 2016
Completion date
December 31, 2020
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, battery